All Posts

Dr. Fahd Qadir, Ph.D., joins the UFDI!

Please join us in welcoming Dr. Fahd Qadir, Ph.D., to the University of Florida Diabetes Institute as a tenure-track Assistant Professor in the Department of Pathology, Immunology and Laboratory Medicine! Dr. Qadir’s lab investigates how pancreatic β-cells maintain mitochondrial resilience during metabolic and inflammatory stress, and…

UF Food is Medicine join forces with FSU ICON-Health and Florida A&M University

This week, members of the UFDI joined colleagues from the UF Food is Medicine Initiative for a collaborative visit with the FSU ICON-Health team and leaders from Florida State University and Florida A&M University. They explored opportunities to strengthen nutrition-focused research and education while engaging communities across…

UFDI and TrialNet attend Friends for Life Orlando 2026 conference

The UFDI is excited to be at the Friends for Life Orlando 2026 conference alongside TrialNet! If you’re attending, stop by and visit our booth at the following times to learn more about the collaborative work of TrialNet and the UFDI in shaping the future of diabetes…

Glycogen drives the sensory activation of POMC neurons

Congratulations to Dr. Matthew Gentry and collaborators on their latest publication in Nature Metabolism! Their study shows that brain glycogen plays an active role in regulating POMC neurons, which are crucial cells involved in appetite and energy balance. By offering new insight into how the brain senses…

Breakthroughs begin here: Revolutionizing diabetes research

Exciting research out of the University of Florida is transforming how we understand and treat diabetes. Scientists at UF Health are making major strides in uncovering the biology behind the disease, with innovative approaches that could reshape the future of care by targeting the root causes of…

Dr. Brittany Bruggeman MD Newsline Interview

We’re pleased to share this interview featuring UFDI’s Dr. Brittany Bruggeman, who discusses her research on fecal elastase as a potential early biomarker for type 1 diabetes, recorded at ADA 2026.